TEMSIROLIMUS Side Effects

7022116-6 | Anaemia, Dehydration, Device Related Infection, Vomiting
on Sep 21, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with thyroid cancer metastatic and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dehydration, device related infection, vomiting. Temsirolimus dosage: Not Provided. During the same period patient was treated with SORAFENIB (Not Provided) (View Sorafenib Review and Sorafenib Label ). Patient was hospitalized.

7021019-0 | Anaemia, Neutropenia
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: anaemia, neutropenia on Sep 20, 2010 from EGYPT Additional patient health information: Male patient , 50 years of age, was diagnosed with renal cell carcinoma and. Temsirolimus dosage: .

7021018-9 | Blood Triglycerides Increased
Adverse event was reported on Sep 20, 2010 by a Female patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma and. Location: EGYPT , 41 years of age, After Temsirolimus was administered, patient had the following side effects: blood triglycerides increased.

7020951-1 | Renal Disorder
on Sep 20, 2010 Male patient from POLAND , weighting 178.6 lb, was diagnosed with renal cell carcinoma, prophylaxis, diabetes mellitus and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: renal disorder. Temsirolimus dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (Not Provided) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), RAMIPRIL (Not Provided) (View Ramipril Review and Ramipril Label ), OMEPRAZOLE (Not Provided) (View Omeprazole Review and Omeprazole Label ), METFORMIN HYDROCHLORIDE (Not Provided) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), FENOFIBRATE (Not Provided) (View Fenofibrate Review and Fenofibrate Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CLONIDINE HYDROCHLORIDE (Not Provided) (View Clonidine Hydrochloride Review and Clonidine Hydrochloride Label ).


7020950-X | Perirectal Abscess
on Sep 21, 2010 Male patient from CZECH REPUBLIC , weighting 154.3 lb, was diagnosed with renal cancer and was treated with Temsirolimus (View Usage). Patient had the following side effects: perirectal abscess. Temsirolimus dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

7020413-1 | Anaemia, Dyspnoea
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: anaemia, dyspnoea on Sep 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 187.0 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Temsirolimus dosage: . Patient was hospitalized.

7018286-6 | Abdominal Pain, Bone Marrow Failure, Diarrhoea, Febrile Neutropenia, Haemoglobin Abnormal, Hypoalbuminaemia, Hypophosphataemia, Nausea, Oral Pain
Adverse event was reported on Sep 27, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: Dose Escalation Scheme On Days 1, 8, And 15 Of A 28-day Cycle) was diagnosed with laryngeal cancer, head and neck cancer (What is head and neck cancer?) and. Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bone marrow failure, diarrhoea, febrile neutropenia, haemoglobin abnormal, hypoalbuminaemia, hypophosphataemia, nausea (What is nausea?), oral pain. During the same period patient was treated with CARBOPLATIN (Auc 5 On Day 1, 400 Mg Total Dose Administered On 15-jul-2010) (View Carboplatin Review and Carboplatin Label ), TAXOL (80 Mg/m^2 Days 1, 8, And 15, Total Dose Administered 150mg 15-jul-2010 And 150mg 22-jul-2010) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7016381-9 | Anaemia, Empyema
on Sep 19, 2010 Male patient from POLAND , weighting 183.0 lb, was diagnosed with renal cell carcinoma, hypertension, prophylaxis, thrombophlebitis, musculoskeletal chest pain, diabetes mellitus and was treated with Temsirolimus (View Usage). Patient had the following side effects: anaemia, empyema. Temsirolimus dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

7016144-4 | Nephrotic Syndrome
on Sep 16, 2010 Male patient from ITALY , weighting 165.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: nephrotic syndrome. Temsirolimus dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

7010448-7 | Abdominal Pain, Bone Marrow Failure, Diarrhoea, Febrile Neutropenia, Haemoglobin Abnormal, Hypoalbuminaemia, Hypophosphataemia, Nausea, Oral Pain
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bone marrow failure, diarrhoea, febrile neutropenia, haemoglobin abnormal, hypoalbuminaemia, hypophosphataemia, nausea (What is nausea?), oral pain on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with laryngeal cancer, head and neck cancer (What is head and neck cancer?) and. Temsirolimus dosage: Dose Escalation Scheme On Days 1, 8, And 15 Of A 28-day Cycle. During the same period patient was treated with CARBOPLATIN (Auc 5 On Day 1) (View Carboplatin Review and Carboplatin Label ), TAXOL (80 Mg/m^2 Days 1, 8, And 15) (View Taxol Review and Taxol Label ). Patient was hospitalized.

7009927-8 | Gastritis, Hypertension
Adverse event was reported on Sep 14, 2010 by a Female patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma and. Location: POLAND , weighting 176.4 lb, Patient had the following side effects: gastritis, hypertension. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

7007854-3 | Gingival Ulceration
on Sep 16, 2010 Male patient from RUSSIAN FEDERATION , weighting 160.9 lb, was diagnosed with renal cancer and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: gingival ulceration. Temsirolimus dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

7001085-9 | Disease Progression
on Sep 15, 2010 Male patient from UNITED KINGDOM , 46 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Temsirolimus dosage: .

6994164-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Phosphorus Decreased, Blood Triglycerides Increased, Dyspnoea, Fatigue, Hyperglycaemia, Hypertension
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood phosphorus decreased, blood triglycerides increased, dyspnoea, fatigue, hyperglycaemia, hypertension on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , 34 years of age, was diagnosed with adrenocortical carcinoma, hypertension and. Temsirolimus dosage: . During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE (74mg (n25 Mg/m^2) Every 4 Weeks) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6987321-3 | Condition Aggravated, Hypertension, Nephrotic Syndrome
Adverse event was reported on Sep 07, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma, cough, hypertension, hypertriglyceridaemia, hypercholesterolaemia and. Location: SERBIA , weighting 149.9 lb, After Temsirolimus was administered, patient had the following side effects: condition aggravated, hypertension, nephrotic syndrome. During the same period patient was treated with CODEINE (Not Provided) (View Codeine Review and Codeine Label ), ACETYLSALICYLIC ACID (Not Provided) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PERINDOPRIL (Not Provided) (View Perindopril Review and Perindopril Label ), BISOPROLOL (Not Provided) (View Bisoprolol Review and Bisoprolol Label ), ROSUVASTATIN (Not Provided) (View Rosuvastatin Review and Rosuvastatin Label ), PANTOTHENIC ACID (Not Provided) (View Pantothenic Acid Review and Pantothenic Acid Label ), PANTHENOL (Not Provided) (View Panthenol Review and Panthenol Label ). Patient was hospitalized.

6985748-7 | Anal Ulcer
on Sep 08, 2010 Male patient from UNITED STATES , 52 years of age, weighting 197.5 lb, was diagnosed with carcinoid tumour, neuroendocrine tumour and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: anal ulcer. Temsirolimus dosage: 25mg On Days 1, 8, 15, And 22 Every 28 Days. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PEPCID (View Pepcid Review and Pepcid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NORVASC (View Norvasc Review and Norvasc Label ), VYTORIN (View Vytorin Review and Vytorin Label ), INSULIN (View Insulin Review and Insulin Label ), POTASSIUM (View Potassium Review and Potassium Label ). Patient was hospitalized.

6979938-7 | Facial Paresis
on Sep 06, 2010 Male patient from SOUTH AFRICA , weighting 176.6 lb, was diagnosed with renal cell carcinoma, hypertension and was treated with Temsirolimus (View Usage). Patient had the following side effects: facial paresis. Temsirolimus dosage: . During the same period patient was treated with PHARMAPRESS (View Pharmapress Review and Pharmapress Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6979932-6 | Decreased Appetite, Fatigue, Nausea, Weight Decreased
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: decreased appetite, fatigue, nausea (What is nausea?), weight decreased on Sep 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.6 lb, was diagnosed with prostate cancer metastatic and. Temsirolimus dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (5 Mg Frequency Not Provided) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), NITROFURANTOIN (100 Mg Frequency Not Provided) (View Nitrofurantoin Review and Nitrofurantoin Label ), CALCIUM PHOSPHATE/CALCIUM SODIUM LACTATE/ERGOCALCIFEROL (Not Provided) (View Calcium Phosphate/calcium Sodium Lactate/ergocalciferol Review and Calcium Phosphate/calcium Sodium Lactate/ergocalciferol Label ), FUROSEMIDE (40 Mg Frequency Not Provided) (View Furosemide Review and Furosemide Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), PRAVASTATIN SODIUM (20 Mg Frequency Not Provided) (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

6971908-8 | Anaemia, Culture Urine Positive, Enterococcus Test Positive, Pyelonephritis, Serratia Test Positive, Urosepsis
Adverse event was reported on Sep 08, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: Temairolimus Weekly Iv) was diagnosed with metastatic carcinoma of the bladder and. Location: UNITED STATES , weighting 134.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, culture urine positive, enterococcus test positive, pyelonephritis, serratia test positive, urosepsis. Patient was hospitalized.

6969864-1 | Cholecystitis Acute
on Aug 27, 2010 Male patient from INDIA , weighting 123.5 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, hypertriglyceridaemia and was treated with Temsirolimus (View Usage). Patient had the following side effects: cholecystitis acute. Temsirolimus dosage: . During the same period patient was treated with AMLODIPINE (5 Mg; Frequency Not Provided) (View Amlodipine Review and Amlodipine Label ), ROSUVASTATIN (Not Provided) (View Rosuvastatin Review and Rosuvastatin Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6968186-2 | Dyspnoea, Fatigue, Hyperglycaemia
on Aug 27, 2010 Male patient from UNITED STATES , 34 years of age, was diagnosed with adrenocortical carcinoma, hypertension and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: dyspnoea, fatigue, hyperglycaemia. Temsirolimus dosage: . During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE (74mg (n25 Mg/m^2) Every 4 Weeks) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6962082-2 | Colitis, Multi-organ Failure, Sepsis
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, multi-organ failure, sepsis (What is sepsis?) on Aug 27, 2010 from INDIA Additional patient health information: Male patient , weighting 160.9 lb, was diagnosed with metastatic renal cell carcinoma, pyrexia, gastritis prophylaxis, vomiting, dental disorder prophylaxis, diabetes mellitus and. Temsirolimus dosage: . During the same period patient was treated with CALPOL (View Calpol Review and Calpol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BETADINE (Gargles 6 Times Daily) (View Betadine Review and Betadine Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized.

6961435-6 | Anaemia, Neutropenia
Adverse event was reported on Mar 17, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma and. Location: EGYPT , 50 years of age, Patient had the following side effects: anaemia, neutropenia.

6961434-4 | Blood Cholesterol Abnormal, Blood Triglycerides Abnormal
on Mar 17, 2010 Female patient from EGYPT , 41 years of age, was diagnosed with renal cell carcinoma and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: blood cholesterol abnormal, blood triglycerides abnormal. Temsirolimus dosage: . During the same period patient was treated with SUTENT (View Sutent Review and Sutent Label ).

6958663-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
on Aug 30, 2010 Female patient from UNITED STATES , 50 years of age, weighting 121.3 lb, was diagnosed with retroperitoneal cancer and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Temsirolimus dosage: 10mg Iv Qweek. During the same period patient was treated with CEDIRANIB (AZD2171) (15mg Po Qd) (View Cediranib (azd2171) Review and Cediranib (azd2171) Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), PEPCID AC (View Pepcid Ac Review and Pepcid Ac Label ). Patient was hospitalized.

6944862-2 | Alanine Aminotransferase Increased, Aortic Calcification, Ascites, Aspartate Aminotransferase Increased, Atelectasis, Bacterial Test Positive, Blood Alkaline Phosphatase Increased, Blood Creatinine Increased
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: alanine aminotransferase increased, aortic calcification, ascites, aspartate aminotransferase increased, atelectasis, bacterial test positive, blood alkaline phosphatase increased, blood creatinine increased on Aug 27, 2010 from INDIA Additional patient health information: Male patient , weighting 160.9 lb, was diagnosed with metastatic renal cell carcinoma, pyrexia, gastritis prophylaxis, vomiting, dental disorder prophylaxis, diabetes mellitus and. Temsirolimus dosage: . During the same period patient was treated with CALPOL (View Calpol Review and Calpol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BETADINE (Gargles 6 Times Daily) (View Betadine Review and Betadine Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized.

6943349-0 | Colitis, Multi-organ Failure, Sepsis
Adverse event was reported on Aug 21, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with metastatic renal cell carcinoma, pyrexia, gastritis prophylaxis, vomiting, dental disorder prophylaxis, diabetes mellitus and. Location: INDIA , weighting 160.9 lb, After Temsirolimus was administered, patient had the following side effects: colitis, multi-organ failure, sepsis (What is sepsis?). During the same period patient was treated with CALPOL (View Calpol Review and Calpol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BETADINE (Gargles 6 Times Daily) (View Betadine Review and Betadine Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized.

6939335-7 | Lung Abscess
on Aug 18, 2010 Male patient from POLAND , weighting 187.4 lb, was diagnosed with renal cell carcinoma, diabetes mellitus, hypertension and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: lung abscess. Temsirolimus dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), METFORMIN (View Metformin Review and Metformin Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6933351-7 | Lung Abscess, Pneumonia
on Aug 09, 2010 Male patient from POLAND , weighting 187.4 lb, was diagnosed with renal cell carcinoma, thrombosis, prophylaxis and was treated with Temsirolimus (View Usage). Patient had the following side effects: lung abscess, pneumonia (What is pneumonia?). Temsirolimus dosage: . During the same period patient was treated with HEPARIN SODIUM (Not Provided) (View Heparin Sodium Review and Heparin Sodium Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6933233-0 | Decreased Appetite, Fatigue, Nausea, Weight Decreased
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: decreased appetite, fatigue, nausea (What is nausea?), weight decreased on Aug 11, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.6 lb, was diagnosed with prostate cancer metastatic and. Temsirolimus dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (5 Mg Frequency Not Provided) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), NITROFURANTOIN (100 Mg Frequency Not Provided) (View Nitrofurantoin Review and Nitrofurantoin Label ), CALCIUM PHOSPHATE/CALCIUM SODIUM LACTATE/ERGOCALCIFEROL (Not Provided) (View Calcium Phosphate/calcium Sodium Lactate/ergocalciferol Review and Calcium Phosphate/calcium Sodium Lactate/ergocalciferol Label ), FUROSEMIDE (40 Mg Frequency Not Provided) (View Furosemide Review and Furosemide Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), PRAVASTATIN SODIUM (20 Mg Frequency Not Provided) (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

6930238-0 | Blood Glucose Increased, Blood Phosphorus Increased, Blood Potassium Decreased, Blood Urea Increased, Mental Status Changes, Platelet Count Decreased, Pneumonia, Pulmonary Cavitation, Respiratory Failure
Adverse event was reported on Aug 12, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with renal cancer, gastritis prophylaxis, diabetes mellitus and. Location: ARGENTINA , weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, blood phosphorus increased, blood potassium decreased, blood urea increased, mental status changes, platelet count decreased, pneumonia (What is pneumonia?), pulmonary cavitation, respiratory failure. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6925352-X | Pneumonitis, Pyrexia
on Aug 05, 2010 Male patient from BELGIUM , weighting 167.6 lb, was diagnosed with renal cell carcinoma, hypercholesterolaemia, rash (What is rash?) and was treated with Temsirolimus (View Usage). Patient had the following side effects: pneumonitis, pyrexia. Temsirolimus dosage: . During the same period patient was treated with OMEPRAZOLE (Not Provided) (View Omeprazole Review and Omeprazole Label ), LIPITOR (Not Provided) (View Lipitor Review and Lipitor Label ), MEDROL (Not Provided) (View Medrol Review and Medrol Label ), AUGMENTIN '125' (Not Provided) (View Augmentin '125' Review and Augmentin '125' Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6920864-7 | Perirectal Abscess
on Aug 02, 2010 Male patient from CZECH REPUBLIC , weighting 154.3 lb, was diagnosed with renal cancer and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: perirectal abscess. Temsirolimus dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6920633-8 | Decreased Appetite
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite on Aug 06, 2010 from FRANCE Additional patient health information: Male patient , weighting 164.2 lb, was diagnosed with renal cell carcinoma, abdominal pain upper, anxiety (What is anxiety?), hypertriglyceridaemia, headache (What is headache?) and. Temsirolimus dosage: . During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM (Not Provided) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), BROMAZEPAM (Not Provided) (View Bromazepam Review and Bromazepam Label ), PAROXETINE HCL (Not Provided) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), FENOFIBRATE (Not Provided) (View Fenofibrate Review and Fenofibrate Label ), BEVACIZUMAB, TEST ARTICLE IN TEMSIROLIMUS STUDY (View Bevacizumab, Test Article In Temsirolimus Study Review and Bevacizumab, Test Article In Temsirolimus Study Label ), ACETAMINOPHEN AND TRAMADOL HCL (Not Provided) (View Acetaminophen And Tramadol Hcl Review and Acetaminophen And Tramadol Hcl Label ). Patient was hospitalized.

6907696-0 | Dizziness, Nausea
Adverse event was reported on Jul 28, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with glioblastoma, headache (What is headache?) and. Location: GERMANY , weighting 159.8 lb, Patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?). During the same period patient was treated with TAVEGIL (^as Per Protocol^) (View Tavegil Review and Tavegil Label ), IBUPROFEN (600 Mg As Needed) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6899933-6 | Febrile Neutropenia, International Normalised Ratio Increased, Pneumonia, Pulmonary Haemorrhage, Septic Shock, Streptococcal Sepsis
on Jul 29, 2010 Male patient from UNITED STATES , 47 years of age, was diagnosed with laryngeal cancer, squamous cell carcinoma and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: febrile neutropenia, international normalised ratio increased, pneumonia (What is pneumonia?), pulmonary haemorrhage, septic shock, streptococcal sepsis. Temsirolimus dosage: 15 Mg Days 1, 8 And 15 Of A 28 Day Cycle. During the same period patient was treated with CARBOPLATIN (Auc 5 On Day 1) (View Carboplatin Review and Carboplatin Label ), TAXOL (80 Mg/m2 Days 1, 8 And 15) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6899932-4 | Bone Marrow Failure, Diarrhoea, Rectal Haemorrhage
on Jul 29, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with laryngeal cancer, head and neck cancer (What is head and neck cancer?) and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, diarrhoea, rectal haemorrhage. Temsirolimus dosage: Dose Escalation Scheme On Days 1, 8, And 15 Of A 28-day Cycle. During the same period patient was treated with CARBOPLATIN (Auc 5 On Day 1) (View Carboplatin Review and Carboplatin Label ), TAXOL (80 Mg/m^2 Days 1, 8, And 15) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6887707-1 | Activities Of Daily Living Impaired, Back Pain, Condition Aggravated, Decreased Appetite, Fatigue, Gait Disturbance, Muscular Weakness, Nausea, Pain In Extremity
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: activities of daily living impaired, back pain (What is back pain?), condition aggravated, decreased appetite, fatigue, gait disturbance, muscular weakness, nausea (What is nausea?), pain in extremity on Jul 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 251.8 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Temsirolimus dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LUPRON (Injections Every Three Months) (View Lupron Review and Lupron Label ), MULTIVIT (View Multivit Review and Multivit Label ), TUMS (View Tums Review and Tums Label ), FLOMAX (View Flomax Review and Flomax Label ), CELEBREX (200 Mg 1-3 Tabs Daily) (View Celebrex Review and Celebrex Label ), FLONASE (50 Mcq/actuation Nasal Spray One Spray Each Nostril Daily As Needed) (View Flonase Review and Flonase Label ), ADVAIR DISKUS 100/50 (500mcg/50mcg Once Daily) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

6884176-2 | Diarrhoea, Perineal Fistula, Proctalgia
Adverse event was reported on Jul 19, 2010 by a Female patient taking Temsirolimus (View Usage) (Dosage: 25mg Over 30min Days 1,8,15,and 22 Of Cycle) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , 74 years of age, After Temsirolimus was administered, patient had the following side effects: diarrhoea, perineal fistula, proctalgia. During the same period patient was treated with EMLA (View Emla Review and Emla Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), LASIX (View Lasix Review and Lasix Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ), MARINOL (View Marinol Review and Marinol Label ), REGLAN (View Reglan Review and Reglan Label ). Patient was hospitalized.

6883893-8 | Decreased Appetite
on Jul 26, 2010 Male patient from FRANCE , weighting 164.2 lb, was diagnosed with renal cell carcinoma, abdominal pain upper, anxiety (What is anxiety?), hypertriglyceridaemia, headache (What is headache?) and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite. Temsirolimus dosage: . During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM (Not Provided) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), BROMAZEPAM (Not Provided) (View Bromazepam Review and Bromazepam Label ), PAROXETINE HCL (Not Provided) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), FENOFIBRATE (Not Provided) (View Fenofibrate Review and Fenofibrate Label ), BEVACIZUMAB, TEST ARTICLE IN TEMSIROLIMUS STUDY (View Bevacizumab, Test Article In Temsirolimus Study Review and Bevacizumab, Test Article In Temsirolimus Study Label ), ACETAMINOPHEN AND TRAMADOL HCL (Not Provided) (View Acetaminophen And Tramadol Hcl Review and Acetaminophen And Tramadol Hcl Label ). Patient was hospitalized.

6883241-3 | Haemorrhagic Stroke
on Jul 26, 2010 Male patient from UNITED STATES , weighting 201.9 lb, was diagnosed with prostate cancer metastatic, urinary tract infection (What is urinary tract infection?), asthenia, anxiety (What is anxiety?), bone pain and was treated with Temsirolimus (View Usage). Patient had the following side effects: haemorrhagic stroke. Temsirolimus dosage: 25 Mg (frequency Not Provided). During the same period patient was treated with BACTRIM (1 Daily) (View Bactrim Review and Bactrim Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ATIVAN (0.5 Mg Prn Daily) (View Ativan Review and Ativan Label ), MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE (5 Mg As Needed) (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6880307-9 | Diarrhoea, Rectal Haemorrhage
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: diarrhoea, rectal haemorrhage on Jul 26, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with laryngeal cancer, head and neck cancer (What is head and neck cancer?) and. Temsirolimus dosage: . During the same period patient was treated with CARBOPLATIN (Auc 5) (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6863377-3 | Nephrotic Syndrome
Adverse event was reported on Jul 15, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with metastatic renal cell carcinoma and. Location: ITALY , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: nephrotic syndrome. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6862595-8 | Pneumonia
on Jul 13, 2010 Male patient from POLAND , weighting 187.4 lb, was diagnosed with renal cell carcinoma and was treated with Temsirolimus (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Temsirolimus dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6860186-6 | Coronary Artery Disease, Syncope
on Jul 09, 2010 Male patient from GERMANY , weighting 191.8 lb, was diagnosed with renal cell carcinoma, coronary artery disease (What is coronary artery disease?) and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?), syncope. Temsirolimus dosage: 25 Mg Once. During the same period patient was treated with ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BEVACIZUMAB (870 Mg Once) (View Bevacizumab Review and Bevacizumab Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6860143-X | Facial Paresis
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: facial paresis on Jul 09, 2010 from SOUTH AFRICA Additional patient health information: Male patient , weighting 176.6 lb, was diagnosed with renal cell carcinoma, hypertension and. Temsirolimus dosage: . During the same period patient was treated with PHARMAPRESS (View Pharmapress Review and Pharmapress Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6839978-5 | Cardiac Failure, Hyponatraemia, Pneumonitis
Adverse event was reported on Jul 07, 2010 by a Male patient taking Temsirolimus (View Usage) (Dosage: ) was diagnosed with metastatic renal cell carcinoma, hypertension, dyslipidaemia, osteopenia and. Location: SLOVAKIA (Slovak Republic) , weighting 142.4 lb, Patient had the following side effects: cardiac failure, hyponatraemia, pneumonitis. During the same period patient was treated with MONOSAN (40 Mg 2x1) (View Monosan Review and Monosan Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), SIMCOR (20 Mg 1x1) (View Simcor Review and Simcor Label ), VITACALCIN (80 Mg 2x1) (View Vitacalcin Review and Vitacalcin Label ), LOKREN (20 Mg 1x1) (View Lokren Review and Lokren Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), ANAPYRIN (View Anapyrin Review and Anapyrin Label ). Patient was hospitalized.

6836484-9 | Haemorrhagic Stroke
on Jul 08, 2010 Male patient from UNITED STATES , weighting 201.9 lb, was diagnosed with prostate cancer metastatic, urinary tract infection (What is urinary tract infection?), asthenia, anxiety (What is anxiety?), bone pain and was treated with Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: haemorrhagic stroke. Temsirolimus dosage: 25 Mg (frequency Not Provided). During the same period patient was treated with BACTRIM (1 Daily) (View Bactrim Review and Bactrim Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ATIVAN (0.5 Mg Prn Daily) (View Ativan Review and Ativan Label ), MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE HCL (5 Mg As Needed) (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6830600-0 | Peritonitis
on Jul 07, 2010 Male patient from POLAND , weighting 176.4 lb, was diagnosed with renal cell carcinoma, glaucoma (What is glaucoma?), diarrhoea and was treated with Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: peritonitis. Temsirolimus dosage: . During the same period patient was treated with PILOCARPINE HYDROCHLORIDE (View Pilocarpine Hydrochloride Review and Pilocarpine Hydrochloride Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6827239-X | Dizziness, Nausea
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?) on Jun 25, 2010 from GERMANY Additional patient health information: Male patient , weighting 159.8 lb, was diagnosed with glioblastoma, headache (What is headache?) and. Temsirolimus dosage: . During the same period patient was treated with TAVEGIL (^as Per Protocol^) (View Tavegil Review and Tavegil Label ), IBUPROFEN (600 Mg As Needed) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.